Bilde av Våbenø, Jon
Bilde av Våbenø, Jon
Institutt for farmasi jon.vabeno@uit.no +4777620909 92096133 Her finner du meg

Jon Våbenø


Førsteamanuensis II


  • Jon Våbenø, Marta Oliva-Santiago, Astrid S. Jørgensen, Stefanie Karlshøj, Mette M. Rosenkilde :
    Identification of a Salt Bridge That Is Functionally Important for Chemokine Receptor CXCR1 but not CXCR2
    ACS Pharmacology & Translational Science 2023 DOI
  • Olav Larsen, Sara Schuermans, Anna Walser, Stavroula Louka, Ida Aaberg Lillethorup, Jon Våbenø m.fl.:
    Chemokine N-terminal-derived peptides differentially regulate signaling by the receptors CCR1 and CCR5
    FEBS Letters 2023 DOI
  • Olav Larsen, Wijnand J.C. van der Velden, Maša Mavri, Sara Schuermans, Pia C. Rummel, Stefanie Karlshøj m.fl.:
    Identification of a conserved chemokine receptor motif that enables ligand discrimination
    Science Signaling 2022 DOI
  • Christian Berg, Michael J. Wedemeyer, Motiejus Melynis, Roman R. Schlimgen, Lasse H. Hansen, Jon Våbenø m.fl.:
    The non-ELR CXC chemokine encoded by human cytomegalovirus UL146 genotype 5 contains a C-Terminal β-hairpin and induces neutrophil migration as a selective CXCR2 agonist
    PLoS Pathogens 2022 DOI
  • Astrid Sissel Jørgensen, Viktorija Daugvilaite, Katia De Filippo, Christian Berg, Masa Mavri, Tau Benned-Jensen m.fl.:
    Biased action of the CXCR4-targeting drug plerixafor is essential for its superior hematopoietic stem cell mobilization
    Communications Biology 2021 DOI
  • Viktoria M. S. Kjær, Loukas Ieremias, Viktorija Daugvilaite, Michael Lückmann, Thomas Frimurer, Trond Ulven m.fl.:
    Discovery of GPR183 Agonists Based on an Antagonist Scaffold
    ChemMedChem 2021 DOI
  • Christian Berg, Viktorija Daugvilaite, Anne Steen, Astrid Sissel Jørgensen, Jon Våbenø, Mette Marie Rosenkilde :
    Inhibition of HIV Fusion by Small Molecule Agonists through Efficacy-Engineering of CXCR4
    ACS Chemical Biology 2018 DOI
  • Massimiliano Pio Di Cagno, Fabrizio Clarelli, Jon Våbenø, Christina Lesley, Sokar Darsim Rahman , Jennifer Cauzzo m.fl.:
    Experimental Determination of Drug Diffusion Coefficients in Unstirred Aqueous Environments by Temporally Resolved Concentration Measurements
    Molecular Pharmaceutics 2018 DOI
  • Markus Baumann, Mohammad Musarraf Hussain, Nina Henne, Daniel Moya Garrote, Stefanie Karlshøj, Torgils Fossen m.fl.:
    Influence of chain length on the activity of tripeptidomimetic antagonists for CXC chemokine receptor 4 (CXCR4)
    Bioorganic & Medicinal Chemistry 2017 ARKIV / DOI
  • Markus Baumann, Lina Marie Nome, Zack Georg Zachariassen, Stepfanie Karlshøj, Torgils Fossen, Mette M. Rosenkilde m.fl.:
    Synthesis of a novel tripeptidomimetic scaffold and biological evaluation for CXC chemokine receptor 4 (CXCR4) antagonism
    Tetrahedron 2017 ARKIV / DOI
  • Zack Georg Zachariassen, Stefanie Karlshøj, Bengt Erik Haug, Mette M. Rosenkilde, Jon Våbenø :
    Probing the molecular interactions between CXC chemokine receptor 4 (CXCR4) and an arginine-based tripeptidomimetic antagonist (KRH-1636)
    Journal of Medicinal Chemistry 2015 ARKIV / DOI
  • Jon Våbenø, Bengt Erik Haug, Mette M. Rosenkilde :
    Progress toward rationally designed small-molecule peptide and peptidomimetic CXCR4 antagonists
    Future Medicinal Chemistry 2015 ARKIV / DOI
  • Stefanie Thiele, Jignesh Mungalpara, Anne Steen, Mette M. Rosenkilde, Jon Våbenø :
    Determination of the binding mode for the cyclopentapeptide CXCR4 antagonist FC131 using a dual approach of ligand modifications and receptor mutagenesis
    British Journal of Pharmacology 2014 ARKIV / DOI
  • Zack Georg Zachariassen, Stefanie Thiele, Erik Berg, Pernille Rasmussen, Torgils Fossen, Mette M. Rosenkilde m.fl.:
    Design, synthesis, and biological evaluation of scaffold-based tripeptidomimetic antagonists for CXC chemokine receptor 4 (CXCR4)
    Bioorganic & Medicinal Chemistry 2014 ARKIV / DOI
  • Jignesh Mungalpara, Zack Georg Zachariassen, Stefanie Thiele, MM Rosenkilde, Jon Våbenø :
    Structure-activity relationship studies of the aromatic positions in cyclopentapeptide CXCR4 antagonists
    Organic and biomolecular chemistry 2013 ARKIV / DOI
  • Jigneshbhai C Mungalpara, Stefanie Thiele, Øystein Eriksen, Jacobus Johannes Eksteen, MM Rosenkilde, Jon Våbenø :
    Rational Design of Conformationally Constrained Cyclopentapeptide Antagonists for C-X-C Chemokine Receptor 4 (CXCR4)
    Journal of Medicinal Chemistry 2012 DOI
  • Carsten Uhd Nielsen, Jon Våbenø, Rikke Andersen, B Brodin, Bente Steffansen :
    Recent advances in therapeutic applications of human peptide transporters
    Expert Opinion on Therapeutic Patents 2005
  • Jon Våbenø, Carsten Uhd Nielsen, Bente Steffansen, Tore Sigvard Lejon, Ingebrigt Sylte, Flemming Steen Jørgensen m.fl.:
    Conformational restrictions in ligand binding to the human intestinal di-/tripeptide transporter: implications for design of hPEPT1 targeted prodrugs
    Bioorganic & Medicinal Chemistry 2005
  • Jon Våbenø, Truls Erik Ingebrigtsen, K Luthman, Tore Sigvard Lejon, Lars Kr Hansen :
    Benzyl-5-[N-(tert-butoxycarbonyl)amino]-4-oxo-6-phenylhexanoate
    Acta Crystallographica Section E: Structure Reports Online 2005
  • Jon Våbenø, Carsten Uhd Nielsen, Truls Erik Ingebrigtsen, Tore Sigvard Lejon, Bente Steffansen, Kristina Luthman :
    Dipeptidomimetic ketomethylene isosteres as pro-moieties for drug transport via the human intestinal di-/tripeptide transporter hPEPT1: Design, synthesis, stability, and biological investigations
    Journal of Medicinal Chemistry 2004
  • Jon Våbenø, Tore Sigvard Lejon, Carsten Uhd Nielsen, Bente Steffansen, Weiqing Chen, Ronald T. Borchardt m.fl.:
    Phe-Gly dipeptidomimetics designed for the di-/tripeptide transporters PEPT1 and PEPT2: Synthesis and biological investigations
    Journal of Medicinal Chemistry 2004
  • J Gullbo, M Tullberg, Jon Våbenø, H Ehrsson, R Lewensohn, P Nygren m.fl.:
    Structure-activity relationship for alkylating dipeptide nitrogen mustard derivatives
    Oncology Research 2003
  • Jon Våbenø, M. Brisander, Tore Sigvard Lejon, K. Luthman :
    Diastereoselective Reduction of a Chiral N- and C-Protected a,b-Unsaturated g-Keto Dipeptidomimetic
    Journal of Organic Chemistry 2002
  • Bengt Erik Haug, Markus Baumann, Karlshøj Stefanie, Mette M. Rosenkilde, Jon Våbenø :
    Scaffold-based tripeptidomimetic CXCR4 antagonists
    2016
  • Markus Baumann, Bengt Erik Haug, Jon Våbenø :
    Synthesis of Bicyclic CXCR4 Antagonists
    Universitetet i Bergen 2016
  • Markus Baumann, Jon Våbenø, Bengt Erik Haug :
    Synthetic studies towards peptidomimetic CXCR4 antagonists
    2015
  • Markus Baumann, Jon Våbenø, Bengt Erik Haug :
    Synthetic studies towards CXCR4 antagonists
    2015
  • Jon Våbenø :
    Vant pris for forskning på HIV
    28. april 2014
  • Markus Baumann, Jon Våbenø, Bengt Erik Haug :
    Synthetic studies towards CXCR4 antagonists
    2014
  • Nina Henne, Jon Våbenø, Bengt Erik Haug :
    Synthetic studies towards CXCR4 antagonists
    2014
  • Zack Georg Zachariassen, S Thiele, MM Rosenkilde, Bengt Erik Haug, Jon Våbenø :
    SAR and Binding Mode for CXCR4 Antagonists Based on an Arg-Arg-Nal Tripeptide Motif
    Biopolymers 2011
  • Jigneshbhai C Mungalpara, S Thiele, MM Rosenkilde, Jon Våbenø :
    SAR and Binding Mode for Cyclopentapeptide CXCR4 Antagonists
    Biopolymers 2011
  • Jon Våbenø :
    HIV Entry Inhibitors: Ligand-Based Design of Peptidomimetic CXCR4 Antagonists
    2007
  • Jon Våbenø :
    Ketomethylene Based Dipeptidomimetics as Pro-Moieties for hPEPT1 Targeted Prodrugs
    2004
  • Jon Våbenø, Carsten Uhd Nielsen, Truls Erik Ingebrigtsen, Tore Sigvard Lejon, Ingebrigt Sylte, Flemming Steen Jørgensen m.fl.:
    Ketomethylene Based Dipeptidomimetics as Pro-Moieties for hPEPT1 Targeted Prodrugs
    2004
  • Jon Våbenø :
    Dipeptidomimetics as Pro-Moieties for hPEPT1 Targeted Prodrugs: Design, Synthesis, Biological Evaluation and Computational Investigations
    UiT Norges arktiske universitet 2004
  • Jon Våbenø, Tore Sigvard Lejon, Carsten Uhd Nielsen, Bente Steffansen, Flemming Steen Jørgensen, Kristina Luthman :
    Structure-Affinity and Structure-Transport Relationships for the Intestinal Oligopeptide Transporter PEPT1
    2003
  • Jon Våbenø, Carsten Uhd Nielsen, Bente Steffansen, Flemming Steen Jørgensen :
    Kan lægemiddelstoffer smugles ind i organismen?
    Lægemiddelforskning 2003
  • Jon Våbenø :
    Design, syntese og testing av cytotoksisk effekt av aminosyre- og dipeptidderivater
    UiT Norges arktiske universitet 1999

  • De 50 siste resultatene fra Cristin vises på siden. Se alle arbeider i Cristin her →